Fact CheckerSign in

NCT06811532Not yet recruiting

Assessing Perfusion of Osteotomized Scapula and Lat Flap

Assessing Perfusion of an Osteotomised Scapula and Latissimus Dorsi Chimeric Free Flap on the Thoracodorsal Artery

Source: ClinicalTrials.gov · Last updated 9 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The gold standard for reconstruction of the jaw is the utilization of a bone free tissue transfer. Scapula reconstruction is an excellent option for elderly patients, those with significant comorbidities and for complex defects with large soft tissue reconstructive requirements. The scapula is supplied by the angular artery and circumflex scapula arteries. No studies have shown with objective measures, the viability of the lateral border of the scapula bone supplied by either the angular artery or circumflex scapula arteries. The aim of this observational study is to demonstrate with objective clinical measures, via SPY-Q software analysis, that the angular artery can adequately supply the scapula tip flap including with a single osteotomy giving two bone segments, in 30 patients who will undergo reconstructive head and neck surgery at LHSC.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
30 (estimated)
First submitted
31 Jan 2025
Start date
7 May 2025
Primary completion date
28 Feb 2027
Lead sponsor
Western University, Canada
NCT number
NCT06811532

What you commit to

  • Study type: Observational
  • Planned participants: 30
  • From 7 May 2025 to the primary completion date, 28 Feb 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • • Younger than 18 years of age
    • History of failing microvascular flaps
    • Hypersensitivity toward ICG or related substances (e.g., imaging agents), defined as (based on ICG product monograph): possibly life-threatening dizziness, severe itching, hives, nausea, difficulty breathing, rash, low blood pressure)
    • Pregnant
    • Breastfeeding
    • Clinically apparent cognitive impairment

Who the study is looking for

  • • Adult patients (18 years and older) seen at the head and neck clinic at London Health Sciences Centre (LHSC)
    • Planned to undergo a maxillary and/or mandibular reconstruction surgery with a scapular tip flap

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.